HK Stock Market Move | ZHAOJIN MINING (01818) Rises Over 11%; Spot Gold Surges Straight Up to Return Above $4,000; Company's Haiyu Gold Mine Capacity Release Is Anticipated
Zhaojin Mining (01818) surged straight up in the afternoon. As of press time, it rose 11.12% to HK$16.99, with a turnover of HK$304 million.
ZHAOJIN MINING (01818) surged straight up in the afternoon, rising 11.12% as of press time to HK$16.99, with turnover of HK$304 million.
On the news front, spot gold surged straight up this afternoon, breaking through the US$4,000/oz mark. The World Gold Council's latest "China National Gold Group Gold Jewellery Demand Trends Report" shows that in the third quarter of 2026, total China National Gold Group Gold Jewellery demand reached 192 tonnes, up 12% year-on-year and up 23% quarter-on-quarter. Meanwhile, according to US media forecasts, in this US midterm election, the Democratic Party will regain control of both the US Senate and House of Representatives, meaning that the Trump administration's subsequent policy advancement will be significantly constrained.
Huatai pointed out that considering gold prices still have strong support in the medium to long term, and that operations are expected to improve after the mine resumes production, it maintains a "Buy" rating. According to the interim report, drilling in the northern part of the Dayingezhuang mining area discovered thick and large ore bodies, achieving a major breakthrough in regional exploration, and the company completed the acquisition of the exploration right surrounding Zhaojin Baiyun and won the bidding for the exploration right in Washijia, Zhaoyuan City, Shandong Province. On the project side, in the first half of the year the company obtained 8 key permits and certificates, including the capacity expansion of the Zaozigou gold mine mining right; the core incremental project, the Haiyu gold mine, has a designed mining and processing scale of 12,000 tonnes/day and a construction period from August 2022 to August 2028, and is expected to commence production in 2028.
Related Articles

Daiwa: China Auto Orders Up 48% Week-on-Week; Momentum Improving for Most Brands

Pfizer Inc. (PFE.US) Q3 Earnings Call: Doubling Down on Oncology and Obesity Pipelines; Once-Monthly Weight-Loss Shot Targets 2028 Approval

New IPO News | Mapletree Capital said to be planning Singapore listing, expected to raise S$1 billion
Daiwa: China Auto Orders Up 48% Week-on-Week; Momentum Improving for Most Brands

Pfizer Inc. (PFE.US) Q3 Earnings Call: Doubling Down on Oncology and Obesity Pipelines; Once-Monthly Weight-Loss Shot Targets 2028 Approval

New IPO News | Mapletree Capital said to be planning Singapore listing, expected to raise S$1 billion






